Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection | Zendy

Shengsen Chen | Zendy; Chao Wang | Zendy; Cui An | Zendy; KangKang Yu | Zendy; Chong Huang | Zendy; Mengqi Zhu | Zendy; Mingquan Chen | Zendy

Open Access

Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection

Author(s) -

Shengsen Chen,

Chao Wang,

Cui An,

KangKang Yu,

Chong Huang,

Mengqi Zhu,

Mingquan Chen

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000491779

Subject(s) - hepatocellular carcinoma , proportional hazards model , medicine , receiver operating characteristic , oncology , stage (stratigraphy) , hazard ratio , biology , confidence interval , paleontology

Carnitine palmitoyltransferase 1A (CPT1A) is a rate-limiting enzyme in the transport of long-chain fatty acids for β-oxidation. Increasing evidence has indicated that CPT1A plays an important role in carcinogenesis. However, the expression and prognostic value of CPT1A in hepatocellular carcinoma (HCC) have not been extensively studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research